Publication:
Prolonged therapy of hepatitis delta for 96 weeks with pegylated-interferon-α-2a plus tenofovir or placebo does not prevent hdv rna relapse after treatment: The hidit-2 study

Simple item page
dc.contributor.authorWedemeyer, H.
dc.contributor.authorYurdaydin, C.
dc.contributor.authorErnst, S.
dc.contributor.authorCaruntu, F. A.
dc.contributor.authorCurescu, M. G.
dc.contributor.authorYalcin, K.
dc.contributor.authorAkarca, U. S.
dc.contributor.authorGürel, Selim
dc.contributor.authorZeuzem, S.
dc.contributor.authorErhardt, A.
dc.contributor.authorLueth, S.
dc.contributor.authorPapatheodoridis, G. V.
dc.contributor.authorKeskin, O.
dc.contributor.authorPort, K.
dc.contributor.authorRadu, M.
dc.contributor.authorCelen, M. K.
dc.contributor.authorIldeman, R.
dc.contributor.authorStift, J.
dc.contributor.authorHeidrich, B.
dc.contributor.authorMederacke, I.
dc.contributor.authorHardtke, S.
dc.contributor.authorKoch, A.
dc.contributor.authorDienes, H. P.
dc.contributor.authorManns, M. P.
dc.contributor.authorHIDIT-2 Study Grp
dc.contributor.buuauthorGÜREL, SELİM
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi
dc.contributor.researcheridHLH-8209-2023
dc.date.accessioned2024-08-15T12:20:18Z
dc.date.available2024-08-15T12:20:18Z
dc.date.issued2014-04-01
dc.descriptionBu çalışma, 09-13, Nisan 2014 tarihlerinde London[İngiltere]’de düzenlenen 49. Annual International Liver Congress of the European-Association-for-the-Study-of-the-Liver Kongresi‘nde bildiri olarak sunulmuştur.
dc.identifier.eissn1600-0641
dc.identifier.endpageS3
dc.identifier.issn0168-8278
dc.identifier.issue1
dc.identifier.startpageS2
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0168827814600064
dc.identifier.urihttps://hdl.handle.net/11452/44080
dc.identifier.volume60
dc.identifier.wos000361961700005
dc.indexed.wosWOS.SCI
dc.indexed.wosWOS.ISTP
dc.language.isoen
dc.publisherElsevier
dc.relation.journalJournal of Hepatology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectScience & technology
dc.subjectLife sciences & biomedicine
dc.subjectGastroenterology & hepatology
dc.subjectGastroenterology & hepatology
dc.titleProlonged therapy of hepatitis delta for 96 weeks with pegylated-interferon-α-2a plus tenofovir or placebo does not prevent hdv rna relapse after treatment: The hidit-2 study
dc.typeMeeting Abstract
dspace.entity.typePublication
relation.isAuthorOfPublicationd7a9ea11-69fc-4122-a365-8fb2123512e6
relation.isAuthorOfPublication.latestForDiscoveryd7a9ea11-69fc-4122-a365-8fb2123512e6

Files

Collections

Yeni Yayınlar